Could biosensors enable better prediction for organ transplantation rejection – a research project with the Department of Medicine, Harvard Medical School Lung Transplantation team
Aqsens Health had a chance to interview Dr. Mohd Moin Khan and Dr. Mudassir Meraj Banday, research fellows at Harvard University, about their research, this collaboration, and how we could use biosensors in the future to help predict the likelihood of rejection in organ transplants. Below are their answers to our questions.
Kicking-off saliva based Parkinson’s disease detection study using E-TRF and biosensors – Interview with Professor Valtteri Kaasinen from University of Turku
Aqsens Health is excited to take part in a cross-disciplinary Parkinson’s disease study in collaboration with Professor Valtteri Kaasinen from The Department of Clinical Neurosciences at the University of Turku. The aim of the study is to improve Parkinson’s disease’s diagnostic accuracy with Aqsens’ E-TRF and biosensor technology and smell detection dogs. We had the pleasure to interview Professor Kaasinen about Parkinson’s disease (PD), its diagnostics, and how this study could help improve diagnostics in the future.
Aqsens Health, Tyks and Auria Biobank join forces for a research study to detect and classify bladder cancer with phage-biosensors
Aqsens Health, Turku University Hospital (Tyks) and Auria Biobank join forces for a bladder cancer research study. This local research collaboration aims to see whether Aqsens Health’s biosensors can be used in the detection and classification of bladder cancer, focusing especially on non-invasive monitoring of bladder cancer tumor development, relapse, and recurrence.
Aqsens Health and Tartu University teaming up to research the capabilities of different phages as biosensors in diagnostics
Aqsens Health is pleased to announce its collaboration with Professor Tambet Teesalu's esteemed research group at the Laboratory of Precision and Nanomedicine, University of Tartu in Estonia. Together, they will delve into extensive research to explore the capabilities of different phages as biosensors.
Next practises and post-pandemic learnings for international research collaboration
Even a small company can greatly benefit from international collaborations, especially in the research and development phase. But why specifically should a health technology or biotechnology start-up look into the possibility of international collaboration?
Aqsens Health and OG Pharmaceuticals partner for an upcoming collaborative research project – Interview with OG Pharmaceuticals Founder & CEO Dr. Zhao Wanzhou
Dr. Zhao answered shared his views about the upcoming collaboration with Aqsens Health, the benefits of urine-based detection, and applying new cancer screening solutions in China.